SynthesisWorld journal of surgery2022
Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.
Synthesis in World journal of surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 27 citations in OpenAlex.
- Emphysematous pyelonephritis-related delayed abdominal wall necrotizing fasciitis: A case report.Medicine · 2026Article
- Two cases of emphysematous cystitis with urinary bladder rupture.Oxford medical case reports · 2026Article
- Emphysematous pyelonephritis with extensive gas accumulations in a patient with poorly controlled diabetes: A case report.Medicine · 2026Article
- Antimicrobial Stewardship and Prognostic Interpretation in Emphysematous Pyelonephritis: Considerations Arising from a Recent Case Series [Letter].Infection and drug resistance · 2026Article
- dNLR, NLR, and NMLR as differential markers for assessing severity and sepsis in emphysematous pyelonephritis.Frontiers in medicine · 2026Article
- Analysis of Pathogenic Bacteria, Drug Resistance and Treatment of Emphysematous Pyelonephritis: A Case Series.Infection and drug resistance · 2026Article
- Emphysematous Pyelonephritis in a Non-diabetic Patient Presenting With Septic Shock: A Report of a Rare Case.Cureus · 2026Article
- Modified National Early Warning Score 2, a reliable early warning system for predicting treatment outcomes in patients with emphysematous pyelonephritis.World journal of nephrology · 2025Article
- Identifying predictors of in-hospital mortality in patients with emphysematous pyelonephritis: insights from a large retrospective cohort.World journal of urology · 2025Article
- Emphysematous pyelonephritis due to Candida albicans in a diabetic patient: A case report.Urology case reports · 2025Article
- Case Report: Massive emphysematous pyelonephritis with short-term relapse.Frontiers in medicine · 2025Article
- Emphysematous pyelonephritis: eight case reports and literature review.Frontiers in medicine · 2025Article
- Clinical image: emphysematous pyelonephritis.Oxford medical case reports · 2024Article
- Emphysematous pyelonephritis caused by Raoultella ornithinolytica: a case report.BMC nephrology · 2024Article
- Report on the diagnosis and treatment of 3 cases of emphysematous pyelonephritis with two different outcomes.Frontiers in medicine · 2024Article
- Emphysematous pyelonephritis with rare and severe iliac vascular complications: a case report and review.Frontiers in medicine · 2024Article
- Risk factors for sepsis and mortality in patients with emphysematous pyelonephritis : a series of 68 cases (case series).Annals of medicine and surgery (2012) · 2024Article
- Comparison of prognosis of five scoring systems in emphysematous pyelonephritis patients requiring intensive care.International urology and nephrology · 2023Article
- Article
- Successful nephrectomy after a failure of non-surgical treatment in emphysematous pyelonephritis: A case report.Heliyon · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEmphysematous pyelonephritis (EP) is a severe necrotizing infection of the renal parenchyma which is associated with significant case mortality. We sought to identify the incidence and predictive risk factors associated with EP mortality.
methodsTwo electronic databases, PubMed and Web of Science, were searched from their inception until June 06, 2021 for relevant articles. Two independent teams reviewed abstracts and extracted data from the selected manuscripts. A meta-analysis has been reported in line with PRISMA 2020 and AMSTAR Guidelines.
resultsOf the 1080 retrieved abstracts, 79 underwent full-text review and 45 studies were included in the final analysis, comprising a total cohort of 1303 patients and 177 mortalities. The pooled prevalence of mortality among the patients with EP disease was 13%. Our analysis found a significantly decreasing trend in mortality rates, an increasing trend in minimally invasive intervention and decreasing trends in emergency nephrectomy in the EP studies from 1985 to 2020. Significant risk factors that were associated with a negative impact on survival of EP patients included sepsis (OR = 15.99), shock (OR = 15.57), disturbance of consciousness (OR = 12.11), thrombocytopenia (OR 7.85), acute renal failure (OR = 5.41), Wan classification I (OR = 4.57), emergency nephrectomy (OR = 3.73), Huang-Tseng classification III-IV (OR = 2.4) and medical management alone (OR = 2.04). Female sex (OR = 0.52) and minimally invasive intervention (OR = 0.47) (percutaneous nephrostomy or ureteral stent placement) were associated with decreased mortality rates.
conclusionsOur study results demonstrated several significant risk factors that could help guide treatment to reduce the mortality risk of EP patients. Clinically, early treatment with a combination of minimally invasive intervention and appropriate medical management may be protective for reducing mortality risk in EP patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.